This HTML5 document contains 199 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n11http://dx.doi.org/10.1007/
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36527473
rdf:type
wikibase:Item
schema:description
2012年论文 article scientific επιστημονικό άρθρο artigo científico artículo científico publicado en 2012 2012年論文 научни чланак teaduslik artikkel научна статия مقالة علمية نشرت في 4 أغسطس 2012 2012年の論文 2012年论文 artigo científico мақолаи илмӣ artículu científicu espublizáu en 2012 2012年論文 scienca artikolo 2012年论文 บทความทางวิทยาศาสตร์ artikull shkencor article scientifique vedecký článok bilimsel makale 2012년 논문 2012 nî lūn-bûn videnskabelig artikel vetenskaplig artikel scientific article published on 4 August 2012 bài báo khoa học מאמר מדעי article científic vědecký článek научная статья наукова стаття, опублікована в серпні 2012 2012年論文 wissenschaftlicher Artikel articolo scientifico scientific article published on 4 August 2012 2012年论文 научни чланак vitenskapelig artikkel სამეცნიერო სტატია 2012年论文 articol științific 2012年論文 artikulong pang-agham 2012年论文 artigo científico naučni članak ৪ আগস্ট ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel 2012 թվականի օգոստոսի 4-ին հրատարակված գիտական հոդված wetenschappelijk artikel 2012年論文 artykuł naukowy scientific article published on 4 August 2012 artikel ilmiah tudományos cikk tieteellinen artikkeli
p:P577
wds:Q36527473-B17BD7F4-BCBD-49FC-B944-A031E6DCD4E3
wdt:P577
2012-08-04T00:00:00Z
p:P2888
wds:Q36527473-2BCDEE06-A8F2-49CD-A384-2FA386100DDD
wdt:P2888
n12:s00262-012-1322-5
p:P2860
wds:Q36527473-1FD885A5-CD7D-46D2-BB94-97D73003A64D wds:Q36527473-244C0511-665A-48BC-AF3E-1818C00E4E41 wds:Q36527473-25C28801-86BB-4273-BDBF-DF8481C746BD wds:Q36527473-3ED80416-9952-4F4B-AD54-B932C3D4CEDB wds:Q36527473-3FD4862F-2C9A-438F-AAAA-7262E5A099CE wds:Q36527473-4051F7E0-6CE0-4E57-9321-18EEE43F84AF wds:Q36527473-45739505-379E-48C0-ABAE-5B190E542374 wds:Q36527473-46287EFF-8903-4080-A889-11F45A974B48 wds:Q36527473-593963D5-EC90-46E4-8EDD-7C95A0BF0168 wds:Q36527473-624B276B-909D-4C66-AD5A-A96F1CF79301 wds:Q36527473-000F2A83-609D-44A2-9ED9-63230C20E378 wds:Q36527473-0308AC6A-901B-40C3-B0DE-96A424D6E974 wds:Q36527473-097499B5-15F1-4D78-847D-9F51A31988A1 wds:Q36527473-0A3B1006-EBD8-4C08-BBFF-2416DFBCA319 wds:Q36527473-12C1B941-3E78-41B0-A9F3-B3FBA0C2D714 wds:Q36527473-15D7FA2C-F28D-4AD0-911A-A81725EA1443 wds:Q36527473-1601E0EF-10E3-40FE-84F2-B0C35F290359 wds:Q36527473-165371D9-D315-42D1-9F36-01DD8C727A3F wds:Q36527473-A5F94C97-C99B-45A8-A510-6FE9B1438AE9 wds:Q36527473-A605A1D7-BBD3-42CC-93F1-5E0C2D4B9298 wds:Q36527473-A6C5EE53-E200-4223-95A0-DAFD9A8A95FB wds:Q36527473-B0459D58-F4C5-4DBA-AEDC-AE45EA5B1144 wds:Q36527473-CBC63B4C-A304-4CA1-B453-BA661F6826C7 wds:Q36527473-CDBAFDE0-E729-4731-A88D-B5EF078F9DFA wds:Q36527473-D81E5E7B-9F9A-4DF2-A8FB-AF06317146A0 wds:Q36527473-DFF73A59-F674-409A-89A3-21653220B0D4 wds:Q36527473-E348F721-3C37-4410-B6F5-1ADEECC53FBA wds:Q36527473-62E7B784-579C-413C-9BE1-5F3FE92B32C5 wds:Q36527473-66965FDA-03BE-41FE-9501-813457331BC2 wds:Q36527473-68514B68-3EC5-44D9-A89A-183ED54ACC60 wds:Q36527473-8096A972-67D9-4638-8BDF-5C59B8E7A769 wds:Q36527473-82C4AB61-8490-474A-B856-FBF40C4ADBA0 wds:Q36527473-850DA8B0-DAEA-4E8F-905A-E90FDF8B46B7 wds:Q36527473-92DA00B8-272F-4353-B6BF-60D1AFDE2A07 wds:Q36527473-94DD28B1-A740-4352-8358-C2AECCC8A023 wds:Q36527473-951F0FE8-32E1-4A7B-AE28-15B5677FBA89 wds:Q36527473-9A235D6D-5D49-47F6-84B3-F4B7EA7A1B9F wds:Q36527473-E8F5E380-FBF9-4046-8845-B850B675C47D wds:Q36527473-F418BACB-94DE-406D-95F0-267340A648D9 wds:Q36527473-F73E076C-9B53-48DC-9550-FED308EC6DA8 wds:Q36527473-FCDCE996-5A88-4B24-9A25-3390E46C5274 wds:Q36527473-FE58D49C-8B97-41DC-A56B-E649074996BE wds:Q36527473-FF5C10AE-643D-41C7-BB2E-298DEF8D7BAA wds:Q36527473-FFA09A15-7E67-44DB-838B-F0C60C5A21AD
wdt:P2860
wd:Q39906933 wd:Q37474385 wd:Q45182740 wd:Q77683633 wd:Q39296306 wd:Q44567479 wd:Q83517336 wd:Q34210036 wd:Q37622609 wd:Q34432972 wd:Q39350478 wd:Q57220173 wd:Q40178764 wd:Q61626227 wd:Q81028669 wd:Q33393740 wd:Q43897080 wd:Q42812053 wd:Q54693667 wd:Q81310240 wd:Q34887495 wd:Q33180284 wd:Q35034703 wd:Q40591372 wd:Q37089001 wd:Q81585299 wd:Q39478685 wd:Q33834057 wd:Q48633948 wd:Q53970403 wd:Q36280089 wd:Q42841495 wd:Q42829424 wd:Q42810754 wd:Q40578942 wd:Q39848326 wd:Q44643829 wd:Q40529159 wd:Q35788112 wd:Q33589833 wd:Q56902548 wd:Q29620731 wd:Q37004584 wd:Q28377964
p:P2093
wds:Q36527473-09985946-3A0E-4644-B211-8EB28195D063 wds:Q36527473-3D08CA72-66BF-4D00-9EF9-14AB2918C90F wds:Q36527473-341C4CFE-A337-44AC-9598-64BCD69D0D77 wds:Q36527473-483973B0-743A-473C-83FD-E08F41C5F5B6 wds:Q36527473-57FCF9EA-34E1-49B5-ADAD-3F9DC3C2EB6A wds:Q36527473-C6B0D5D8-5D83-4D09-94C9-7BA2DAD79477 wds:Q36527473-AECF1129-A152-470D-A6DD-0DDBDB0A3FC0 wds:Q36527473-AB62EEDB-F645-4860-B22F-87CB749339CE wds:Q36527473-DC43A25A-8B08-4246-9DF9-2971C7E06C8C
wdt:P2093
Sara I Pai Sofia Lyford-Pike Shiwen Peng Annie Wu Drew Hannaman John R Saunders T-C Wu Chien-Fu Hung Belinda Akpeng
rdfs:label
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
skos:prefLabel
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
schema:name
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
p:P1476
wds:Q36527473-355635A0-24BA-4649-8FDE-C760E9523DA9
wdt:P1476
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine
p:P304
wds:Q36527473-9AF1732E-AAD4-4D1B-9D23-5AE479C0AFE2
wdt:P304
171-182
p:P31
wds:Q36527473-6C3E116B-BB0F-40CD-87FB-BFB8F3CFA40A
wdt:P31
wd:Q13442814
p:P698
wds:Q36527473-994C4F2A-B696-4222-B193-E5234C33D23F
wdtn:P698
n13:23011589
wdt:P698
23011589
p:P1433
wds:Q36527473-CD416D92-6D28-4A88-B1A5-C8091B9E99F2
wdt:P1433
wd:Q5031409
p:P433
wds:Q36527473-91438EE2-CAF9-4B5D-A504-DDE600D81C10
p:P478
wds:Q36527473-93DC3921-61E1-4470-B036-ECDAAF4A0545
wdt:P433
1
wdt:P478
62
p:P356
wds:Q36527473-D0590D58-E33F-4A5C-895A-DC8C05E82CFB
wdtn:P356
n11:S00262-012-1322-5
wdt:P356
10.1007/S00262-012-1322-5
p:P932
wds:Q36527473-7483DE49-EE9C-4C75-96AD-EC678DD44EA4
wdt:P932
3543472